The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage

Clinical trial NCT06563817 · RECRUITING

Trial details

NCT number: NCT06563817
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Communicating Hydrocephalus Cerebral Intraventricular Hemorrhage Secondary Normal Pressure Hydrocephalus Post Hemorrhagic Hydrocephalus

Start date: 2024-08-01
Primary completion: 2025-05-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.